EndoC-bH3 — PKBSM0561GQKP
Summary
EndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 days
Sample Terms
Sample Name
EndoC-bH3
Classifications
human beta cell line
Growth Medium
DMEM low glucose (1 g/L) supplemented with 2% fatty acid free BSA , 10 mM nicotinamide, 5.5 µg/mL human transferrin, 6.7 ng/mL sodium selenite, 50 µM β-mercaptoethanol, 100 U/mL penicillin and 100 µg/mL streptomycin
Age
unknown
Coating Condition
ECM, fibronectin
Excision Status
excised
Taxa
Homo sapiens
Description
EndoC-bH3 cells treated with 4-hydroxy tamoxifen for three weeks from GSE207816
Publication Identifiers
File SetsReport view
2 items
Treatments
1 item
Term Name
Purpose
Type
Summary
activation
chemical
Treatment of 1 mM 4-hydroxy tamoxifen for 21 days
Attribution
Funding
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
